These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22404917)

  • 41. [Non-channel drugs to prevent atrial fibrillation].
    Fazekas T; Liszkai G
    Orv Hetil; 2005 Nov; 146(45):2287-94. PubMed ID: 16304807
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanisms underlying atrial-selective block of sodium channels by Wenxin Keli: Experimental and theoretical analysis.
    Hu D; Barajas-Martínez H; Burashnikov A; Panama BK; Cordeiro JM; Antzelevitch C
    Int J Cardiol; 2016 Mar; 207():326-34. PubMed ID: 26820362
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of a novel multifunctional resveratrol derivative for the treatment of atrial fibrillation.
    Baczko I; Liknes D; Yang W; Hamming KC; Searle G; Jaeger K; Husti Z; Juhasz V; Klausz G; Pap R; Saghy L; Varro A; Dolinsky V; Wang S; Rauniyar V; Hall D; Dyck JR; Light PE
    Br J Pharmacol; 2014 Jan; 171(1):92-106. PubMed ID: 24102184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanisms of atrial-selective block of Na⁺ channels by ranolazine: II. Insights from a mathematical model.
    Nesterenko VV; Zygmunt AC; Rajamani S; Belardinelli L; Antzelevitch C
    Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1615-24. PubMed ID: 21821780
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Electrophysiological effects of ranolazine in a goat model of lone atrial fibrillation.
    Opačić D; van Hunnik A; Zeemering S; Dhalla A; Belardinelli L; Schotten U; Verheule S
    Heart Rhythm; 2021 Apr; 18(4):615-622. PubMed ID: 33232809
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Roles of I
    Kambayashi R; Goto A; Izumi-Nakaseko H; Takei Y; Matsumoto A; Kawai S; Sugiyama A
    J Pharmacol Sci; 2022 Aug; 149(4):175-178. PubMed ID: 35717070
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased atrial effectiveness of flecainide conferred by altered biophysical properties of sodium channels.
    O' Brien S; Holmes AP; Johnson DM; Kabir SN; O' Shea C; O' Reilly M; Avezzu A; Reyat JS; Hall AW; Apicella C; Ellinor PT; Niederer S; Tucker NR; Fabritz L; Kirchhof P; Pavlovic D
    J Mol Cell Cardiol; 2022 May; 166():23-35. PubMed ID: 35114252
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel ion channel targets in atrial fibrillation.
    Hancox JC; James AF; Marrion NV; Zhang H; Thomas D
    Expert Opin Ther Targets; 2016 Aug; 20(8):947-58. PubMed ID: 26918581
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of a highly selective acetylcholine-activated K+ channel blocker on experimental atrial fibrillation.
    Machida T; Hashimoto N; Kuwahara I; Ogino Y; Matsuura J; Yamamoto W; Itano Y; Zamma A; Matsumoto R; Kamon J; Kobayashi T; Ishiwata N; Yamashita T; Ogura T; Nakaya H
    Circ Arrhythm Electrophysiol; 2011 Feb; 4(1):94-102. PubMed ID: 21156770
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Theoretical possibilities for the development of novel antiarrhythmic drugs.
    Varró A; Biliczki P; Iost N; Virág L; Hála O; Kovács P; Mátyus P; Papp JG
    Curr Med Chem; 2004 Jan; 11(1):1-11. PubMed ID: 14754422
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synergistic Anti-arrhythmic Effects in Human Atria with Combined Use of Sodium Blockers and Acacetin.
    Ni H; Whittaker DG; Wang W; Giles WR; Narayan SM; Zhang H
    Front Physiol; 2017; 8():946. PubMed ID: 29218016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Balance between sodium and calcium currents underlying chronic atrial fibrillation termination: An in silico intersubject variability study.
    Liberos A; Bueno-Orovio A; Rodrigo M; Ravens U; Hernandez-Romero I; Fernandez-Aviles F; Guillem MS; Rodriguez B; Climent AM
    Heart Rhythm; 2016 Dec; 13(12):2358-2365. PubMed ID: 27569443
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
    Lévy S
    Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tertiapin, a selective IKACh blocker, terminates atrial fibrillation with selective atrial effective refractory period prolongation.
    Hashimoto N; Yamashita T; Tsuruzoe N
    Pharmacol Res; 2006 Aug; 54(2):136-41. PubMed ID: 16725344
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vernakalant: A novel agent for the termination of atrial fibrillation.
    Finnin M
    Am J Health Syst Pharm; 2010 Jul; 67(14):1157-64. PubMed ID: 20592320
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A multiple ion channel blocker, NIP-142, for the treatment of atrial fibrillation.
    Tanaka H; Hashimoto N
    Cardiovasc Drug Rev; 2007; 25(4):342-56. PubMed ID: 18078434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atrial-selective block of sodium channels by acehytisine in rabbit myocardium.
    Fan X; Wang C; Wang N; Ou X; Liu H; Yang Y; Dang X; Zeng X; Cai L
    J Pharmacol Sci; 2016 Dec; 132(4):235-243. PubMed ID: 27107824
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of small-conductance calcium-activated potassium channels in atrial electrophysiology and fibrillation in the dog.
    Qi XY; Diness JG; Brundel BJ; Zhou XB; Naud P; Wu CT; Huang H; Harada M; Aflaki M; Dobrev D; Grunnet M; Nattel S
    Circulation; 2014 Jan; 129(4):430-40. PubMed ID: 24190961
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rate-dependent effects of vernakalant in the isolated non-remodeled canine left atria are primarily due to block of the sodium channel: comparison with ranolazine and dl-sotalol.
    Burashnikov A; Pourrier M; Gibson JK; Lynch JJ; Antzelevitch C
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):400-8. PubMed ID: 22322366
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation.
    Antzelevitch C; Burashnikov A
    Ann N Y Acad Sci; 2010 Feb; 1188():78-86. PubMed ID: 20201889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.